The Christie NHS Foundation Trust in Withington, Manchester, manages the Christie Hospital, one of the largest cancer treatment centres of its type in Europe.

During the past decade, Christie Hospital NHS Trust conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christie Hospital NHS Trust" are "Isocitrate Dehydrogenase" (1 trials), "Leukemia, Myeloid" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Christie Hospital NHS Trust" in a lesser frequency.

Most popular intervention types in "Christie Hospital NHS Trust" are "Drug" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG-221" (1 trials), "Azacitidine" (1 trials), "BSC" (1 trials), "Gene-modified (GM) T cell therapy" (1 trials) and "Intermediate-dose cytarabine (IDAC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christie Hospital NHS Trust" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Christie Hospital NHS Trust". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Christie Hospital NHS Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christie Hospital NHS Trust, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".